NICE Guidance - April 2022
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of April 2022. This month there are two guidelines that impact upon primary care.
The Epilepsies in children, young people and adults guideline has been published. It covers diagnosing and managing epilepsy in children, young people and adults in primary and secondary care, and referral to tertiary services. It aims to improve diagnosis and treatment for different seizure types and epilepsy syndromes, and reduce the risks for people with epilepsy.
The Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults guideline has been published. It covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z‑drugs and antidepressants in primary and secondary care.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Drug Safety Update - April 2022 | CKS Updates - April 2022 » |
Leave a Comment